Testing effectiveness (Phase 2)Study completedNCT01375751
What this trial is testing
Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study
Who this might be right for
Hypercholesterolemia, Familial
Amgen 168